ICCC (ImmuCell Corporation) Stock Financials & Earnings | Market Cap Arena

ICCC (ImmuCell Corporation) Stock Financials & Earnings | Market Cap Arena

ICCCImmuCell Corporation

Mkt Cap$60M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Revenue (TTM)$28M

Net Income (TTM)-$1M

EPS (TTM)-$0.11

Free Cash Flow (TTM)$715,351

Gross Margin41.4%

Op. Margin6.0%

Net Margin-3.8%

FCF Margin2.6%

P/S Ratio (TTM)2.2x

P/E Ratio (TTM)—

YoY Rev Growth+4.3%

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$3M	$301K	-$2M
Q2 23	$4M	$1M	-$1M
Q3 23	$5M	$1M	-$1M
Q4 23	$5M	$1M	-$1M
Q1 24	$7M	$2M	-$300K
Q2 24	$5M	$1M	-$1M
Q3 24	$6M	$2M	-$575K
Q4 24	$8M	$3M	$621K
Q1 25	$8M	$3M	$1M
Q2 25	$6M	$3M	$570K
Q3 25	$6M	$2M	$20K
Q4 25	$8M	$3M	-$58K

Valuation

Quarter	P/S	P/E
Q1 23	3.7x	—
Q2 23	3.8x	—
Q3 23	3.7x	—
Q4 23	3.4x	—
Q1 24	2.8x	—
Q2 24	2.6x	—
Q3 24	2.5x	—
Q4 24	2.2x	—
Q1 25	2.2x	—
Q2 25	2.1x	33.8x
Q3 25	2.1x	25.6x
Q4 25	2.2x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q4 22	-$1M	-$3M
Q1 23	-$3M	-$3M
Q2 23	-$681K	-$1M
Q3 23	-$508K	-$928K
Q4 23	-$723K	-$804K
Q1 24	$419K	$348K
Q2 24	$582K	$471K
Q3 24	-$639K	-$728K
Q4 24	-$3K	-$199K
Q1 25	$2M	$1M
Q2 25	$2M	$1M
Q3 25	-$1M	-$2M

Capital Expenditures

CapEx

Quarter	CapEx
Q4 22	$1M
Q1 23	$682K
Q2 23	$708K
Q3 23	$421K
Q4 23	$81K
Q1 24	$70K
Q2 24	$111K
Q3 24	$88K
Q4 24	$196K
Q1 25	$329K
Q2 25	$155K
Q3 25	$594K

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 23	-42.6%	+5.0%
Q2 23	-8.5%	+8.0%
Q3 23	+12.5%	+21.6%
Q4 23	+30.3%	+10.0%
Q1 24	+110.6%	+32.5%
Q2 24	+54.9%	+41.8%
Q3 24	+11.4%	+0.1%
Q4 24	+52.1%	+16.9%
Q1 25	+11.2%	-8.0%
Q2 25	+17.8%	-14.3%
Q3 25	-8.4%	-16.7%
Q4 25	-1.6%	+7.8%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q4 22	$65K	1.7%
Q1 23	$96K	2.8%
Q2 23	$76K	2.1%
Q3 23	$96K	1.8%
Q4 23	$101K	2.0%
Q1 24	$81K	1.1%
Q2 24	$98K	1.8%
Q3 24	$78K	1.3%
Q4 24	$69K	0.9%
Q1 25	$52K	0.6%
Q2 25	$67K	1.0%
Q3 25	$73K	1.3%

OpEx Breakdown

Quarter	R&D	G&A	S&M	SG&A
Q1 23	$1M	$567K	$879K	—
Q2 23	$1M	$529K	$720K	—
Q3 23	$1M	$515K	$817K	—
Q4 23	$1M	$523K	$672K	—
Q1 24	$1M	$532K	$801K	—
Q2 24	$1M	$602K	$985K	—
Q3 24	$786K	$528K	$844K	—
Q4 24	$819K	$555K	$836K	—
Q1 25	$757K	$623K	$857K	—
Q2 25	$832K	$720K	$696K	—
Q3 25	$694K	$729K	$919K	—
Q4 25	$759K	—	—	$2M

Revenue Segments

Quarter

Revenue by Geography

Quarter

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$3M	$0	$3M
Q2 23	$1M	$0	$1M
Q3 23	$2M	$0	$2M
Q4 23	$979K	$0	$979K
Q1 24	$960K	$0	$960K
Q2 24	$1M	$0	$1M
Q3 24	$4M	$0	$4M
Q4 24	$4M	$0	$4M
Q1 25	$5M	$0	$5M
Q2 25	$6M	$0	$6M
Q3 25	$4M	$0	$4M
Q4 25	$4M	$0	$4M

Shares Outstanding

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change
Q1 23	8M	-0.0%
Q2 23	8M	+0.0%
Q3 23	8M	+0.0%
Q4 23	8M	+0.0%
Q1 24	8M	+0.0%
Q2 24	8M	+0.8%
Q3 24	8M	+4.5%
Q4 24	9M	+9.4%
Q1 25	9M	+0.5%
Q2 25	9M	+0.6%
Q3 25	9M	+0.2%
Q4 25	9M	+0.0%

Revenue Per Employee

Revenue / Employee

Year	Revenue/Employee	Employees
FY 14	$223K	34
FY 15	$222K	46
FY 16	$212K	45
FY 17	$222K	47
FY 18	$215K	51
FY 19	$254K	54
FY 20	$252K	61
FY 21	$241K	80
FY 22	$251K	74
FY 23	$221K	79
FY 24	$353K	75
FY 25	$369K	75